Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Page 1
Neurofilament-light and contactin-1 association with long-term brain atrophy in natalizumab-treated relapsing-remitting multiple sclerosis.
Mult Scler. 2022 Dec;28(14):2231-2242. doi: 10.1177/13524585221118676. Epub 2022 Sep 3.
Mult Scler. 2022.
PMID: 36062492
Free PMC article.
Plasma glial fibrillary acidic protein and neurofilament light chain in relation to disability worsening in multiple sclerosis.
Pauwels A, Van Schependom J, Devolder L, Van Remoortel A, Nagels G, Bjerke M, D'hooghe MB.
Pauwels A, et al.
Mult Scler. 2022 Oct;28(11):1685-1696. doi: 10.1177/13524585221094224. Epub 2022 May 21.
Mult Scler. 2022.
PMID: 36059263
Item in Clipboard
Early versus delayed treatment with glatiramer acetate: Analysis of up to 27 years of continuous follow-up in a US open-label extension study.
Ford CC, Cohen JA, Goodman AD, Lindsey JW, Lisak RP, Luzzio C, Pruitt A, Rose J, Rus H, Wolinsky JS, Kadosh SE, Bernstein-Hanlon E, Stark Y, Alexander JK.
Ford CC, et al.
Mult Scler. 2022 Oct;28(11):1729-1743. doi: 10.1177/13524585221094239. Epub 2022 Jun 29.
Mult Scler. 2022.
PMID: 35768939
Free PMC article.
Clinical Trial.
Item in Clipboard
The clinical spectrum of haemorrhagic CNS inflammatory demyelinating lesions.
Hardy TA, Guo Y, Flanagan EP, Lucchinetti CF, Tobin WO.
Hardy TA, et al.
Mult Scler. 2022 Oct;28(11):1710-1718. doi: 10.1177/13524585221094241. Epub 2022 May 17.
Mult Scler. 2022.
PMID: 35581949
Item in Clipboard
Is the effect of drugs in progressive MS only due to an effect on inflammation? A subgroup meta-analysis of randomised trials.
Capanna M, Signori A, Sormani MP.
Capanna M, et al.
Mult Scler. 2022 Oct;28(11):1744-1751. doi: 10.1177/13524585221094944. Epub 2022 May 17.
Mult Scler. 2022.
PMID: 35581943
Item in Clipboard
Long-term trajectories of employment status, workhours and disability support pension status, after a first episode of CNS demyelination.
Zarghami A, van der Mei I, Hussain MA, Claflin SB, Bessing B, Simpson-Yap S, Ponsonby AL, Lechner-Scott J, Broadley S, Blizzard L, Taylor BV; AusLong Investigator Group.
Zarghami A, et al.
Mult Scler. 2022 Oct;28(11):1793-1807. doi: 10.1177/13524585221089900. Epub 2022 May 13.
Mult Scler. 2022.
PMID: 35549477
Item in Clipboard
Emergency department use by persons with MS: A population-based descriptive study with a focus on infection-related visits.
Graf J, Ng HS, Zhu F, Zhao Y, Wijnands JM, Evans C, Fisk JD, Marrie RA, Tremlett H.
Graf J, et al.
Mult Scler. 2022 Oct;28(11):1825-1828. doi: 10.1177/13524585221078497. Epub 2022 Mar 1.
Mult Scler. 2022.
PMID: 35232298
Free PMC article.
Item in Clipboard
Gadolinium-enhanced brain lesions in multiple sclerosis relapse.
Martín-Aguilar L, Presas-Rodriguez S, Rovira À, Capellades J, Massuet-Vilamajó A, Ramió-Torrentà L, Tintoré M, Brieva-Ruiz L, Moral E, Cano-Orgaz A, Blanco Y, Batlle-Nadal J, Carmona O, Gea M, Hervás-García JV, Ramo-Tello C.
Martín-Aguilar L, et al.
Neurologia (Engl Ed). 2022 Sep;37(7):557-563. doi: 10.1016/j.nrleng.2021.10.005.
Neurologia (Engl Ed). 2022.
PMID: 36064284
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite